We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The role of gabapentin in treating diseases with cutaneous manifestations and pain.
- Authors
Scheinfeld, Noah
- Abstract
Gabapentin was first approved by the FDA in 1993 as an add-on treatment for partial epileptic seizures. In May of 2002, it was approved as treatment for post-herpetic neuralgia by the Food and Drug Administration. It appears to be a promising agent in the treatment of pain, alterations of sensation and pruritus associated with dermatological disease, but no review of these uses exists.
- Publication
International journal of dermatology, 2003, Vol 42, Issue 6, p491
- ISSN
0011-9059
- Publication type
Journal Article
- DOI
10.1046/j.1365-4362.2003.01831.x